Comparative Observation on Acupoint Application and Rosuvastatin Calcium Tablets on Blood Lipid Levels with 96 Cases Patients of Coronary Heart Disease(CHD)
Cui Danyan
Abstract
Cui Danyan
Abstract
Objective:To comparatively observe the acupoint application and Rosuvastatin Calcium Tablets on the blood lipid levels with 96 cases patients of coronary heart disease. Method:96 cases of patients with coronary heart disease were randomly divided into 2 groups,the meridian sticking group(48 cases)for coronary heart disease were applied 1/d;drug treatment group(48 cases)for Rosuvastatin Calcium Tablets 10 mg/night,po. Six weeks later,we reviewed blood lipid and liver function indicators. Results:Comparing two groups' effects on lipid levels,acupoint sticking group on the improvement of TC,TG,HDL-C and LDL-C was better than that of Rosuvastatin Calcium Tablets group. The difference was statistically significant(P0.05). But there was no influence for LP(a)(P0.05). Conclusion:Coronary heart disease(CHD) acupoint sticking can obviously improve the TC,TG,HDL-C and LDL-C index and reduce the risk of cardiovascular events. And it effectively avoids the lipid-lowering drugs in patients with liver damage.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective:To comparatively observe the acupoint application and Rosuvastatin Calcium Tablets on the blood lipid levels with 96 cases patients of coronary heart disease. Method:96 cases of patients with coronary heart disease were randomly divided into 2 groups,the meridian sticking group(48 cases)for coronary heart disease were applied 1/d;drug treatment group(48 cases)for Rosuvastatin Calcium Tablets 10 mg/night,po. Six weeks later,we reviewed blood lipid and liver function indicators. Results:Comparing two groups' effects on lipid levels,acupoint sticking group on the improvement of TC,TG,HDL-C and LDL-C was better than that of Rosuvastatin Calcium Tablets group. The difference was statistically significant(P0.05). But there was no influence for LP(a)(P0.05). Conclusion:Coronary heart disease(CHD) acupoint sticking can obviously improve the TC,TG,HDL-C and LDL-C index and reduce the risk of cardiovascular events. And it effectively avoids the lipid-lowering drugs in patients with liver damage.
Key concepts: Medicine, Rosuvastatin, Coronary heart disease, Internal medicine, Lipid profile, Blood lipids, Calcium, Cardiology